First came the COVID-19 pandemic. Then came the COVID-19 vaccines. Then came millions of COVID-19 vaccine reports of suspected side effects. What are the implications of that?
Research / 25 November 2022
In a weeklong groundbreaking study-a-thon with the IMI EHDEN consortium, UMC researchers found longitudinal health data could boost preliminary analysis of drug-event combinations.
Research / 28 October 2022
With low reporting of medication errors in Africa, understanding the scale of the problem and the reasons behind it should help in efforts to improve the situation.
Research / 31 August 2022
Jean Marie Vianney Habarugira and Albert Figueras are all for using pharmacovigilance databases for AMR surveillance. Hear them out on the latest episode of Drug Safety Matters.
Research / 04 July 2022
Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.